Speakers

Seth D. Levy, Esquire, Davis Wright Tremaine LLP, Los Angeles, CA
Hans Sauer, PhD, JD, Associate General Counsel for Intellectual Property
Biotechnology Industry Organization, Washington, DC

Description

Intellectual property is at the core of most life sciences businesses. As a result, issues involving patents often find their way into seemingly unrelated areas of legal practice. This program will provide information that every life sciences lawyer should know about how his/her practice may be affected by patent law issues, as well as the impact that the practice may have on clients' intellectual property. Topics will include, among others, the Hatch-Waxman Act; pending biosimilars legislation and the patent issues this creates with follow-on biologics; the way in which representations made to the FDA can impact the scope and enforceability of patent rights; when a clinical trial amounts to a "public use" in a manner that may undermine patent rights; and pending patent reform legislation.

Continuing Legal Education (CLE)

CLE information will be provided to registrants at the URL where you access the materials. Find out more information on CLEs for teleconferences.

Registration Details
(Faxed registrations must be received by 5:00 pm on Wednesday, April 23, 2008.)

$190 Member
$250 Non-Member
$95 Gov't/Academic